Mayo Clinic partners with IT company Leidos

Mayo Clinic has teamed up with Fortune 500 company Leidos in a strategic collaboration to develop and market tools, technologies and therapeutics to engage patients and families in their care.

Leidos, based in Reston, Virginia, is an information technology, engineering and science solutions and services company with 32,000 employees. Mayo Clinic, based in Rochester, Minnesota, is one of the nation’s top hospital systems and well known for its partnership strategy.

The two organizations plan to build an accelerator on Mayo Clinic’s campus in Jacksonville, Florida, within its life science incubator campus, which was established to advance new ideas and products from the research lab. The accelerator will use Ledios’ integration solutions and applied public health applications.

“The shared values and deep passion for transforming healthcare make this collaboration a powerful force for the advancement of innovative methods and quick translation of these solutions across the health care ecosystem,” Jon Scholl, Leidos Health group president, said in a statement. “The clinical knowledge of the Mayo Clinic combined with our technical expertise has the potential to truly transform the quality of healthcare in the future.”

The collaboration is the latest partnership from Mayo Clinic. The organization announced a three-year strategic alliance last year with a virtual reality developer to create joint surgical VR simulations and educational products.

“We look forward to combining the power of our two organizations that will help us advance new solutions to solve the most complex healthcare challenges,” Kent Thielen, MD, CEO of Mayo Clinic in Florida, said in the announcement. “Working together will allow us to spark a vibrant ecosystem to bring innovation to the direct benefit of patients more quickly.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.